Estimating cost-offsets of new medications: Use of new antipsychotics and mental health costs for schizophrenia

Statistics in Medicine

Volumn 30, Issue 16, 2011, Pages 1971-1988

  O'Malley, A James ^a   Frank, R G ^a,b   Normand, S L T ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bivariate likelihood; Instrumental variables; Medicaid cost data; Method of moments; Simultaneous equations; Two stage regression

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ACCURACY; ARTICLE; BAYES THEOREM; CAUSAL MODELING; COST BENEFIT ANALYSIS; DATA ANALYSIS; DRUG COST; HEALTH CARE COST; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; MAXIMUM LIKELIHOOD METHOD; MEDICAID; MENTAL HEALTH CARE; OUTCOME ASSESSMENT; PREDICTION; RANDOMIZATION; REGRESSION ANALYSIS; SCHIZOPHRENIA; SENSITIVITY ANALYSIS; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; STRUCTURAL EQUATION MODELING; UNITED STATES;

ADULT; ANTIPSYCHOTIC AGENTS; BAYES THEOREM; BIOSTATISTICS; DRUG COSTS; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; LIKELIHOOD FUNCTIONS; MALE; MODELS, STATISTICAL; REGRESSION ANALYSIS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 79959244407     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4245     Document Type: Article

References (31)

1. VanLare JM, Conway PH, Sox HC. Five next steps for a new national program for comparative-effectiveness research. New England Journal of Medicine 2010; 362:970-973.
2. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41-55.
3. Imbens G, Angrist J. Identification and estimation of local average treatment effects. Econometrica 1994; 62:467-476.
4. Terza JV, Basu A, Rathouz P. Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling. Journal of Health Economics 2008; 27(3):531-543.
5. Goldman DP, Bhattacharya J, McCaffrey DF, Duan N, Leibowitz AA, Joyce GF, Morton SC. Effect of insurance on mortality in an HIV-positive population in care. Journal of the American Statistical Association 2001; 96(455):883-894.
6. Lichtenberg F. Are the benefits of new drugs worth their costs? Health Affairs 2001; 20:41-51.
7. Rosenheck R, Leslie D, Sindelar J, Miller E, Lin H, Stroup T, McEvoy J, Davis S, Keefe R, Swartz M. Cost effectiveness of second generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. American Journal of Psychiatry 2006; 163:2080-2089.
8. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables (Disc: P456-472). Journal of the American Statistical Association 1996; 91:444-455.
9. Robins JM. Data, design, and background knowledge in etiologic inference. Epidemiology 2001; 11:313-320.
10. Joffe MM, Small D, Brunelli S, Ten Have T, Feldman HI. Extended instrumental variables estimation of overall effects. International Journal of Biostatistics 2008; 4 (Epub April 7, 2008).
11. Brookhart MA, Stürmer T, Gylnn RJ, Rassen J, Schneeweiss S. Confounding control in healthcare database research: Challenges and potential approaches. Medical Care 2010; 48(6(S1)):S114-S120.
12. Small DS. Sensitivity analysis for instrumental variables regression with overidentifying restrictions. Journal of the American Statistical Association 2007; 102(479):1049-1058.
13. Wooldridge J. Econometric Analysis of Cross Section and Panel Data. MIT Press: Cambridge, MA, 2002.
14. Wald A. The fitting of straight lines if both variables are subject to error. Annals of Mathematical Statistics 1940; 11:284-300.
15. Campbell JY, Lo AW, Mackinlay AC. The Econometrics of Financial Markets. Princeton University Press: NJ, 1997.
16. Bhattacharya J, Goldman D, McCaffrey D. Estimating probit models with self-selected treatments. Statistics in Medicine 2006; 25(3):389-413.
17. Maddala G. Limited-dependent and Qualitative Variables in Econometrics. Cambridge University Press: Cambridge, 1978.
18. Hausman J. Specification tests in econometrics. Econometrica 1978; 46:1251-1271.
19. Zeng F, O'Leary JF, Sloss EM, Lopez MS, Dhanani N, Melnick G. The effect of medicare health maintenance organizations on hospitalization rates for ambulatory care-sensitive conditions. Medical Care 2006; 44(10):900-907.
20. Copas JB, Li HG. Inference for non-random samples (Disc: P77-95). Journal of the Royal Statistical Society, Series B: Methodological 1997; 59:55-77.
21. Heckman JJ. Dummy endogenous variables in a simultaneous equation system. Econometrica 1978; 46:931-960.
22. Rotnitzky A, Robins J. Analysis of semi-parametric regression models with non-ignorable non-response. Statistics in Medicine 1997; 16:81-102.
23. Spiegelhalter DJ, Thomas A, Best N, Lunn D. WinBugs Version 1.4: User Manual. Medical Research Council Biostatistics Unit., 2003.
24. Best N, Cowles M, Vines K. Convergence Diagnosis and Output Analysis Software for Gibbs Sampling Output. MRC Biostatistics Unit, Institute of Public Health: Robinson Way, Cambridge, U.K., 1995.
25. Duan N. Smearing estimate: A nonparametric retransformation method. Journal of the American Statistical Association 1983; 78:605-610.
26. Angrist J, Pischke JS. Mostly Harmless Econometrics: An Empiricist's Companion. Princeton University Press: Princeton, NJ, 2009.
27. Vytlacil E. Independence, monotonicity, and latent index models: an equivalence result. Econometrica 2002; 70(1):331-341.
28. Heckman JJ, Vytlacil E. Structural equations, treatment effects and econometric policy evaluation. Econometrica 2005; 73(3):669-738.
29. Staiger D, Stock JH. Instrumental variables regression with weak instruments. Econometrica 1997; 65:557-586.
30. Teixeira-Pinto A, Normand SLT. Correlated bivariate continuous and binary outcomes: issues and applications. Statistics in Medicine 2008; 28:1753-1773.
31. Lieberman JA, Stroup TS, McEvoy J, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD. Effectiveness of antipsychotic drugs in patients with schizophrenia. New England Journal of Medicine 2005; 353:1209-1223.